SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-15-030169
Filing Date
2015-04-24
Accepted
2015-04-24 16:44:12
Documents
5
Effectiveness Date
2015-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A a15-9764_3defa14a.htm DEFA14A 36143
2 GRAPHIC g97643bgi001.gif GRAPHIC 79931
3 GRAPHIC g97643bgi002.gif GRAPHIC 112983
4 GRAPHIC g97643bgi003.gif GRAPHIC 60703
5 GRAPHIC g97643bgi004.gif GRAPHIC 36549
  Complete submission text file 0001104659-15-030169.txt   437626
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35119 | Film No.: 15792309
SIC: 2834 Pharmaceutical Preparations